WISCONSIN ALUMNI RES FOUNDATION WARF has a total of 33 patent applications. It increased the IP activity by 33.0%. Its first patent ever was published in 2004. It filed its patents most often in United States, Australia and EPO (European Patent Office). Its main competitors in its focus markets biotechnology, pharmaceuticals and foods and drinks are GENERA SPA, HOLM PER SONNE and SEMENTIS LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 23 | |
#2 | Australia | 4 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | WIPO (World Intellectual Property Organization) | 2 | |
#5 | Canada | 1 | |
#6 | Luxembourg | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Foods and drinks | |
#4 | Measurement | |
#5 | Environmental technology | |
#6 | Micro-structure and nano-technology | |
#7 | Chemical engineering |
# | Name | Total Patents |
---|---|---|
#1 | Kawaoka Yoshihiro | 24 |
#2 | Neumann Gabriele | 14 |
#3 | Ping Jihui | 9 |
#4 | Murakami Shin | 4 |
#5 | Horimoto Taisuke | 4 |
#6 | Ralph John | 2 |
#7 | Karasin Alexander I | 2 |
#8 | Olsen Christopher W | 2 |
#9 | Watanabe Tokiko | 2 |
#10 | Withers Saunia | 2 |
Publication | Filing date | Title |
---|---|---|
WO2020223699A1 | Improved influenza virus replication for vaccine development | |
WO2020033527A2 | Recombinant biologically contained filovirus vaccine | |
LU100392B1 | A method to determine the throughput speed of a pore | |
AU2017221444A1 | Improved influenza B virus replication for vaccine development | |
US2017058265A1 | Generation of infectious influenza viruses from virus-like particles | |
US2017067029A1 | Influenza virus replication for vaccine development | |
US2015368621A1 | Mutations that confer genetic stability to additional genes in influenza viruses | |
AU2004273660A1 | Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin D derivatives and parathyroid hormone |